Associate Professor Rishi Kotecha - tested the safety and effectiveness of a ... cent to 81.6 per cent. Associate Professor Kotecha, co-head of The K…
Exploring opportunities for early diagnosis and intervention and the impact this has on improving family healthcare.
Our team aims to better understand how the immune response to immune challenges, such as viral infections can influence the risk of developing asthma…
Few studies exist investigating lung function trajectories of those born preterm; however growing evidence suggests some individuals experience incre…
Stillbirth is a critical public health issue worldwide. While the rates in high-income countries are relatively low, there are persistent between-cou…
Sullivan P, ……… Kotecha RS, Dalla-Pozza L, et al. Clinical and
Oommen J, Yeoh DK, Cheung LC, Gottardo NG, Kotecha RS. Blinatumomab limits humoral antibody
va D, de Kraa R, Shipman P, de Wet R, Kotecha RS. Successful treatment of a child with
To determine the incidence, serotype distribution and clinical outcomes of invasive pneumococcal disease in children with acute lymphoblastic leukaem…
KMT2A-rearranged acute lymphoblastic leukaemia (ALL) represents a high risk subtype of childhood ALL. Historical treatment strategies have comprised…